# AMERICAN COASTAL INSURANCE Corp: financial statements, quarterly

ACIC · Nasdaq · CIK 1401521 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/acic.md) · [Financials](/companies/acic/financials.md) · [Filings](/companies/acic/filings.md) · [Insiders](/companies/acic/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/acic/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [52.5](/filings/0001401521-24-000118.md) | [51.3 d](/filings/0001401521-26-000015.md) | [66.6](/filings/0001401521-25-000073.md) | [68.7](/filings/0000950170-25-105221.md) | [82.1](/filings/0001401521-25-000133.md) | [79.3 d](/filings/0001401521-26-000015.md) | [72.2](/filings/0001401521-26-000029.md) | [86.5](/filings/0001401521-26-000037.md) | [90.4](/filings/0001401521-25-000133.md) | [86.4 d](/filings/0001401521-26-000015.md) | [71.2](/filings/0001401521-26-000029.md) | [82.6](/filings/0001401521-26-000037.md) |
| Operating income | $m | [18.3](/filings/0001401521-24-000118.md) | [19.1 d](/filings/0001401521-26-000015.md) | [30.6](/filings/0001401521-25-000073.md) | [24.1](/filings/0000950170-25-105221.md) | [36.1](/filings/0001401521-25-000133.md) | [8.9 d](/filings/0001401521-26-000015.md) | [25.1](/filings/0001401521-26-000029.md) | [36.2](/filings/0001401521-26-000037.md) | [41.7](/filings/0001401521-25-000133.md) | [37.3 d](/filings/0001401521-26-000015.md) | [25.5](/filings/0001401521-26-000029.md) | [28.5](/filings/0001401521-26-000037.md) |
| Interest expense | $m | [2.7](/filings/0001401521-24-000118.md) | [2.7 d](/filings/0001401521-26-000015.md) | [2.7](/filings/0001401521-25-000073.md) | [3.4](/filings/0000950170-25-105221.md) | [3.1](/filings/0001401521-25-000133.md) | [2.8 d](/filings/0001401521-26-000015.md) | [2.7](/filings/0001401521-26-000029.md) | [2.7](/filings/0001401521-26-000037.md) | [2.7](/filings/0001401521-25-000133.md) | [2.7 d](/filings/0001401521-26-000015.md) | [2.3](/filings/0001401521-26-000029.md) | [2.3](/filings/0001401521-26-000037.md) |
| Income tax | $m | [3.0](/filings/0001401521-24-000118.md) | [2.8 d](/filings/0001401521-26-000015.md) | [7.7](/filings/0001401521-25-000073.md) | [5.8](/filings/0000950170-25-105221.md) | [8.8](/filings/0001401521-25-000133.md) | [3.0 d](/filings/0001401521-26-000015.md) | [6.5](/filings/0001401521-26-000029.md) | [9.5](/filings/0001401521-26-000037.md) | [9.9](/filings/0001401521-25-000133.md) | [10.1 d](/filings/0001401521-26-000015.md) | [6.5](/filings/0001401521-26-000029.md) | [6.5](/filings/0001401521-26-000037.md) |
| Net income | $m | [10.6](/filings/0001401521-24-000118.md) | [14.3 d](/filings/0001401521-26-000015.md) | [23.6](/filings/0001401521-25-000073.md) | [19.1](/filings/0000950170-25-105221.md) | [28.1](/filings/0001401521-25-000133.md) | [4.9 d](/filings/0001401521-26-000015.md) | [21.3](/filings/0001401521-26-000029.md) | [26.4](/filings/0001401521-26-000037.md) | [32.5](/filings/0001401521-25-000133.md) | [26.6 d](/filings/0001401521-26-000015.md) | [19.3](/filings/0001401521-26-000029.md) | [21.9](/filings/0001401521-26-000037.md) |
| Diluted EPS | $ per share | [0.24](/filings/0001401521-24-000118.md) | not reported | [0.48](/filings/0001401521-25-000073.md) | [0.39](/filings/0000950170-25-105221.md) | [0.57](/filings/0001401521-25-000133.md) | not reported | [0.43](/filings/0001401521-26-000029.md) | [0.53](/filings/0001401521-26-000037.md) | [0.65](/filings/0001401521-25-000133.md) | not reported | [0.39](/filings/0001401521-26-000029.md) | [0.44](/filings/0001401521-26-000037.md) |
| Basic EPS | $ per share | [0.24](/filings/0001401521-24-000118.md) | not reported | [0.50](/filings/0001401521-25-000073.md) | [0.40](/filings/0000950170-25-105221.md) | [0.59](/filings/0001401521-25-000133.md) | not reported | [0.44](/filings/0001401521-26-000029.md) | [0.55](/filings/0001401521-26-000037.md) | [0.67](/filings/0001401521-25-000133.md) | not reported | [0.40](/filings/0001401521-26-000029.md) | [0.46](/filings/0001401521-26-000037.md) |

- Revenue: us-gaap:Revenues
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [111](/filings/0001401521-23-000139.md) | [139](/filings/0001401521-24-000118.md) | [285](/filings/0001401521-24-000043.md) | [229](/filings/0001401521-24-000099.md) | [183](/filings/0001401521-24-000118.md) | [137](/filings/0001401521-26-000015.md) | [167](/filings/0001401521-25-000073.md) | [315](/filings/0000950170-25-105221.md) | [268](/filings/0001401521-25-000133.md) | [199](/filings/0001401521-26-000037.md) | [117](/filings/0001401521-26-000029.md) | [219](/filings/0001401521-26-000037.md) |
| Total assets | $m | [1,150](/filings/0001401521-23-000139.md) | [1,062](/filings/0001401521-25-000032.md) | [1,077](/filings/0001401521-24-000043.md) | [1,311](/filings/0001401521-24-000099.md) | [1,144](/filings/0001401521-24-000118.md) | [1,216](/filings/0001401521-26-000015.md) | [1,160](/filings/0001401521-25-000073.md) | [1,347](/filings/0000950170-25-105221.md) | [1,179](/filings/0001401521-25-000133.md) | [1,073](/filings/0001401521-26-000037.md) | [997](/filings/0001401521-26-000029.md) | [1,244](/filings/0001401521-26-000037.md) |
| Total liabilities | $m | [1,029](/filings/0001401521-23-000139.md) | [894](/filings/0001401521-25-000032.md) | [873](/filings/0001401521-24-000043.md) | [1,088](/filings/0001401521-24-000099.md) | [884](/filings/0001401521-24-000118.md) | [980](/filings/0001401521-26-000015.md) | [899](/filings/0001401521-25-000073.md) | [1,055](/filings/0000950170-25-105221.md) | [852](/filings/0001401521-25-000133.md) | [755](/filings/0001401521-26-000037.md) | [665](/filings/0001401521-26-000029.md) | [903](/filings/0001401521-26-000037.md) |
| Long-term debt | $m | not reported | [150](/filings/0001401521-24-000024.md) | not reported | not reported | not reported | [150](/filings/0001401521-25-000032.md) | not reported | not reported | not reported | [150](/filings/0001401521-26-000015.md) | not reported | not reported |
| Shareholders' equity | $m | [121](/filings/0001401521-24-000118.md) | [169](/filings/0001401521-26-000015.md) | [204](/filings/0000950170-25-105221.md) | [223](/filings/0001401521-25-000133.md) | [260](/filings/0001401521-25-000133.md) | [236](/filings/0001401521-26-000037.md) | [261](/filings/0001401521-26-000037.md) | [292](/filings/0001401521-26-000037.md) | [327](/filings/0001401521-25-000133.md) | [318](/filings/0001401521-26-000037.md) | [332](/filings/0001401521-26-000037.md) | [341](/filings/0001401521-26-000037.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [47.9 d](/filings/0001401521-24-000118.md) | [48.9 d](/filings/0001401521-26-000015.md) | [124](/filings/0001401521-25-000073.md) | [126 d](/filings/0000950170-25-105221.md) | [(9.0) d](/filings/0001401521-25-000133.md) | [1.6 d](/filings/0001401521-26-000015.md) | [26.4](/filings/0001401521-26-000029.md) | [128 d](/filings/0001401521-26-000037.md) | [(35.6) d](/filings/0001401521-25-000133.md) | [(47.8) d](/filings/0001401521-26-000015.md) | [(5.7)](/filings/0001401521-26-000029.md) | [58.5 d](/filings/0001401521-26-000037.md) |
| Capital expenditure | $m | [(0.1) d](/filings/0001401521-24-000118.md) | [0.0 d](/filings/0001401521-26-000015.md) | [0.0](/filings/0001401521-25-000073.md) | [0.0 d](/filings/0000950170-25-105221.md) | [0.0 d](/filings/0001401521-25-000133.md) | [0.0 d](/filings/0001401521-26-000015.md) | [0.1](/filings/0001401521-26-000029.md) | [0.0 d](/filings/0001401521-26-000037.md) | [0.0 d](/filings/0001401521-25-000133.md) | [0.1 d](/filings/0001401521-26-000015.md) | [0.1](/filings/0001401521-26-000029.md) | [0.2 d](/filings/0001401521-26-000037.md) |
| Dividends paid | $m | [0.0 d](/filings/0001401521-23-000139.md) | [0.0 d](/filings/0001401521-26-000015.md) | not reported | not reported | not reported | not reported | [0.0](/filings/0001401521-26-000029.md) | [0.0 d](/filings/0001401521-26-000037.md) | not reported | not reported | [36.6](/filings/0001401521-26-000029.md) | [0.0 d](/filings/0001401521-26-000037.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [43.1](/filings/0001401521-23-000139.md) | [43.6](/filings/0001401521-24-000043.md) | [43.8](/filings/0001401521-24-000099.md) | [44.1](/filings/0001401521-24-000118.md) | [49.0](/filings/0001401521-25-000073.md) | [49.4](/filings/0000950170-25-105221.md) | [49.5](/filings/0001401521-25-000133.md) | [49.6](/filings/0001401521-26-000029.md) | [49.6](/filings/0001401521-26-000037.md) | [49.9](/filings/0001401521-25-000133.md) | [49.8](/filings/0001401521-26-000029.md) | [49.3](/filings/0001401521-26-000037.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 48,464,047 at 2026-05-01, from the cover of the [10-Q filed 2026-05-08](/filings/0001401521-26-000029.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:38 ET. No prices; not investment advice.